Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2

Berdel, 1987, 449 Modest, 1989, Cancer Chemother. Pharmacol, 24, 359 Munder, 1981, 441 Berdel, 1980, Eur. J. Cancer, 16, 1199, 10.1016/0014-2964(80)90179-6 Andreesen, 1987, Lipids, 22, 836, 10.1007/BF02535540 Hochhut, 1990, Cancer Res. Clin. Oncol, 116, 459, 10.1007/BF01612994 Honma, 1983, Cancer Chemother. Pharmacol, 11, 73, 10.1007/BF00254248 Unger, 1989, Acta Oncologica, 28, 213, 10.3109/02841868909111249 Muschiol, 1987, Lipids, 22, 930, 10.1007/BF02535558 Hilgard, 1988, Eur. J. Cancer Clin. Oncol, 24, 1457, 10.1016/0277-5379(88)90336-7 Unger, 1989, Onkologie, 37, 219 Unger, 1990, J. Cancer Res. Clin. Oncol, 116, 993 Noseda, 1989, Exp. Mol. Pathol, 50, 69, 10.1016/0014-4800(89)90057-9 Grunicke, 1990, J. Cancer Res. Clin. Oncol, 116, 889 Kuo, 1990, J. Cancer Res. Clin. Oncol, 116, 889 Helfman, 1983, Cancer Res, 43, 2955 Vehmeyer, K., Eibl, H., and Unger, C., submitted for publication. Boyum, 1976, Scand. J. Immunol, 5, 9, 10.1111/j.1365-3083.1976.tb03851.x Scheurich, 1987, J. Immunol, 138, 1786, 10.4049/jimmunol.138.6.1786 van Blitterswijk, 1987, Lipids, 22, 820, 10.1007/BF02535537 Fleer, 1990, Onkologie, 13, 295, 10.1159/000216779 Grosman, 1990, Immunopharmacology, 19, 113, 10.1016/0162-3109(90)90046-H Oishi, 1988, J. Biol. Chem, 263, 6865, 10.1016/S0021-9258(18)68724-1 van Corven, 1989, Cell, 59, 45, 10.1016/0092-8674(89)90868-4